Hainan Poly Pharm. Co., Ltd (SHE:300630)

Market Cap	496.69M
Revenue (ttm)	1.31B
Net Income (ttm)	-106.04M
Shares Out	558.08M
EPS (ttm)	-0.24
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	36,818,340
Average Volume	40,493,374
Open	0.9000
Previous Close	0.8800
Day's Range	0.8600 - 0.9500
52-Week Range	0.5600 - 13.4800
Beta	0.18
RSI	32.65
Earnings Date	Aug 29, 2025

About Hainan Poly Pharm.

Hainan Poly Pharm. Co., Ltd. engages in research, development, production, and sale of pharmaceutical drugs in China and internationally. The company’s dosage formulations comprise of tablets, capsules, granules, ointments, eye drops, pre-infusion, injection, lyophilization, and oral solutions. It also offers pharmaceutical preparations, active pharmaceutical ingredients, other raw materials, excipients, prescription drugs, and contract manufacturing and contract development and manufacturing services. Hainan Poly Pharm. Co., Ltd. was founded i...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1992
• Employees: 1,565
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300630

Financial Performance

In 2023, Hainan Poly Pharm.'s revenue was 1.30 billion, a decrease of -19.43% compared to the previous year's 1.62 billion. Earnings were 85.92 million, a decrease of -70.87%.